Case Study: Euthymics Bioscience streamlines FDA-compliant document exchange with GlobalSign PDF Signing

Euthymics Bioscience Chooses GlobalSign’s FDA-compliant Digital Signature Solution to Streamline Document Exchange

Euthymics Bioscience, a biopharmaceutical company, was experiencing extended project timelines and high overhead costs due to an inefficient, paper-based process for signing and distributing documents. The company needed an FDA-compliant digital signature solution to streamline its workflows. They chose the PDF Signing solution from vendor GlobalSign to meet this challenge.

GlobalSign implemented its FDA-compliant PDF Signing solution, which uses certificates on secure USB tokens and is seamlessly recognized by Adobe Reader. This allowed Euthymics to digitally sign and share documents from remote locations. The results for GlobalSign's solution included widespread adoption, significantly reduced overhead costs for storage and distribution, and faster document delivery times.

Euthymics Bioscience

Anthony McKinney

President and CEO